CD34 and sickle cell disease: Persistence of edited cells was assessed by the mean proportion of alleles with the intended genetic modification in CD34+ cells of bone marrow and peripheral blood; persistence was shown to be maintained at ≥60% of alleles in the cells of both subjects with transfusion-dependent thalassemia and sickle cell disease.